Medborn Pharma Private Limited
About Medborn Pharma Private Limited
Data last updated:
Medborn Pharma Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the preventive healthcare segment of the healthcare sector. It was incorporated on 29 May 2018.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2018PTC334624. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Anita Bansal and Manju Bansal.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Shop No 11 Ground Floor Dda Market Rp Block Pitampura, New Delhi, Delhi, India – 110034.
Company details
Contact details
Medborn Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShop No 11 Ground Floor Dda Market Rp Block Pitampura, New Delhi, Delhi, India – 110034
- IndustryHealthcare, Preventive Health Services
To see the full contact details of Medborn Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medborn Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medborn Pharma Private Limited, buy the company report.
Financials of Medborn Pharma Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medborn Pharma Private Limited, buy the company report.
Board of directors of Medborn Pharma Private Limited
Medborn Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anita Bansal | Director | 29 May 2018 | 8 Years 4 Months | As last reported |
| Manju Bansal | Director | 29 May 2018 | 8 Years 4 Months | As last reported |
Auditor
Medborn Pharma Private Limited is audited by TAPAN GUPTA & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TAPAN GUPTA & ASSOCIATES | FY 2023 | 024604N |
Shareholding
The shareholding of Medborn Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medborn Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medborn Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medborn Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medborn Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Medborn Pharma Private Limited, buy the company report.
Recent activity
Medborn Pharma Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anita Bansal was appointed as Director on 29 May 2018.
Frequently asked questions
Medborn Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Medborn Pharma was a private limited company based in New Delhi, Delhi, India. The company worked in preventive health services, within the healthcare industry. It was incorporated on 29 May 2018 and is registered under CIN U24100DL2018PTC334624. The company has been struck off by the Registrar of Companies and is no longer operational.
Medborn Pharma had 2 directors:
- Anita Bansal - Director
- Manju Bansal - Director
The CIN (Corporate Identification Number) of Medborn Pharma is U24100DL2018PTC334624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Medborn Pharma is at Shop No 11 Ground Floor Dda Market Rp Block Pitampura, New Delhi, Delhi, India – 110034.
Medborn Pharma was incorporated on 29 May 2018. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Medborn Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2019 are in the company report.
No. Medborn Pharma has 1 GST registration on record and it is cancelled or inactive.
Medborn Pharma operated in the healthcare industry, in the preventive health services segment. It worked in this industry before it was struck off.
Anita Bansal was appointed as Director on 29 May 2018. Manju Bansal was appointed as Director on 29 May 2018.